KCM
HZNP
Kingdon Capital Management’s Horizon Therapeutics Public Limited Company Ordinary Shares HZNP Stock Holding History
| Quarter | Market Value | Status | Shares |
Shares Change % | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2017
Q2 | – | Sell |
-2,959,258
| Closed | -$43.7M | – | 136 |
|
|
2017
Q1 | $43.7M | Sell |
2,959,258
-3,723,360
| -56% | -$55M | 2.4% | 5 |
|
|
2016
Q4 | $108M | Sell |
6,682,618
-134,285
| -2% | -$2.17M | 5.23% | 1 |
|
|
2016
Q3 | $124M | Buy |
6,816,903
+2,761,736
| +68% | +$50.1M | 5.67% | 2 |
|
|
2016
Q2 | $66.8M | Buy |
4,055,167
+2,878,892
| +245% | +$47.4M | 3.67% | 2 |
|
|
2016
Q1 | $19.5M | Sell |
1,176,275
-1,343,680
| -53% | -$22.3M | 1.07% | 22 |
|
|
2015
Q4 | $54.6M | Buy |
2,519,955
+1,270,321
| +102% | +$27.5M | 2.66% | 6 |
|
|
2015
Q3 | $24.8M | Sell |
1,249,634
-2,076,195
| -62% | -$41.2M | 1.19% | 15 |
|
|
2015
Q2 | $116M | Sell |
3,325,829
-371,311
| -10% | -$12.9M | 4.52% | 1 |
|
|
2015
Q1 | $96M | Sell |
3,697,140
-2,377,476
| -39% | -$61.7M | 4.07% | 1 |
|
|
2014
Q4 | $78.3M | Buy |
6,074,616
+3,927,012
| +183% | +$50.6M | 3.4% | 3 |
|
|
2014
Q3 | $26.4M | Buy |
2,147,604
+91,520
| +4% | +$1.12M | 1.18% | 14 |
|
|
2014
Q2 | $32.5M | Buy |
2,056,084
+23,720
| +1% | +$375K | 1.25% | 7 |
|
|
2014
Q1 | $30.7M | Buy |
2,032,364
+533,085
| +36% | +$8.05M | 1.57% | 5 |
|
|
2013
Q4 | $11.4M | Buy |
1,499,279
+325,551
| +28% | +$2.48M | 0.52% | 43 |
|
|
2013
Q3 | $3.96M | Buy |
1,173,728
+425,100
| +57% | +$1.43M | 0.19% | 110 |
|
|
2013
Q2 | $1.84M | Buy |
+748,628
| New | +$1.84M | 0.11% | 144 |
|